Back
Cabaletta Bio Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
41
CABA
Cabaletta Bio
Last Price:
$1.87
Seasonality Move:
15.34%
Sell
46
EYPT
EyePoint Pharmaceuticals
Last Price:
$7.23
Seasonality Move:
-2.36%
Sell
41
Cabaletta Bio (CABA)
is a Sell
Is Cabaletta Bio a Buy, Sell or Hold?
-
The current Cabaletta Bio [CABA] share price is $1.87. The Score for CABA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
CABA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $7.24. The Score for EYPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CABA Stock Price Chart
What is Cabaletta Bio's stock price today?
-
The Cabaletta Bio share price today is $1.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CABA is experiencing slight selling pressure.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $7.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing slight buying pressure.
CABA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 63.26 | Buy |
Chaikin Money Flow: | -381930 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.22 - 1.82) | Buy |
Bollinger Bands (100): | (1.31 - 2.33) | Buy |
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 64.33 | Buy |
Chaikin Money Flow: | 112236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.77 - 6.89) | Buy |
Bollinger Bands (100): | (5.52 - 7.54) | Buy |
CABA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.82 | Buy |
20-day SMA: | 1.58 | Buy |
50-day SMA: | 1.42 | Buy |
200-day SMA: | 2.88 | Sell |
8-day EMA: | 1.81 | Buy |
20-day EMA: | 1.65 | Buy |
50-day EMA: | 1.6 | Buy |
200-day EMA: | 3.7 | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.35 | Buy |
20-day SMA: | 6.22 | Buy |
50-day SMA: | 5.96 | Buy |
200-day SMA: | 7.77 | Sell |
8-day EMA: | 6.57 | Buy |
20-day EMA: | 6.3 | Buy |
50-day EMA: | 6.25 | Buy |
200-day EMA: | 7.95 | Sell |
Cabaletta Bio Earnings Growth & CABA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.14 per share, and an increase next year of $0.24 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.09 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Cabaletta Bio Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
EyePoint Pharmaceuticals Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |